Perimeter Enterprise Value Over E B I T D A from 2010 to 2024
| PINK Stock | CAD 0.60 0.02 3.23% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (3.63) | Current Value (3.82) | Quarterly Volatility 4.49272586 |
Check Perimeter Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Perimeter Medical's main balance sheet or income statement drivers, such as Interest Expense of 116 K, Other Operating Expenses of 13.6 M or Tax Provision of 0.0, as well as many indicators such as Price To Sales Ratio of 186, Dividend Yield of 0.0 or PTB Ratio of 3.66. Perimeter financial statements analysis is a perfect complement when working with Perimeter Medical Valuation or Volatility modules.
Perimeter | Enterprise Value Over E B I T D A |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Perimeter Stock Analysis
When running Perimeter Medical's price analysis, check to measure Perimeter Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perimeter Medical is operating at the current time. Most of Perimeter Medical's value examination focuses on studying past and present price action to predict the probability of Perimeter Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perimeter Medical's price. Additionally, you may evaluate how the addition of Perimeter Medical to your portfolios can decrease your overall portfolio volatility.